• You are here:
  • Home /
  • English blog /
  • Biopharma Company Ascendis Pharma Prepares for Further Growth by Partnering with CatalystOne Solutions

Biopharma Company Ascendis Pharma Prepares for Further Growth by Partnering with CatalystOne Solutions

Ascendis Pharma is a progressive Danish biopharmaceutical company which has experienced major growth over the past couple of years. The company has boomed after being listed on the Nasdaq stock exchange in 2015. They are now bringing their 160 employee strong company from start-up to grown-up, expecting to grow the company significantly over the next couple of years.

Jesper-Cassøe-Andersen_AscendisPharma

“To support further international growth, we need to streamline our HR processes, move from manual to digital, and ensure high quality and secure handling of our HR data”, says Jesper Cassøe Andersen, VP Global Human Resources at Ascendis Pharma. “And we really need to do it now, as we see a modern HCM system as an important building block in succeeding with our growth plans.”

Jesper Cassøe Andersen_AscendisPharma“Facing substantial growth, one of HR’s main responsibilities is to support managers in their leadership and make sure that they have the very best support in recruiting, onboarding, and retaining top talent”, says Jesper. “In CatalystOne, we believe we have found a partner that provides us with a modern HR technology platform, a great partnership to help us succeed, but above all, a user friendly solution that will bring true value across the whole organisation – to our managers, our employees – and HR.”

 

"We see a modern HCM system as an important building block in succeeding with our growth plans.

Jesper Cassøe Andersen, VP Global Human Resources at Ascendis Pharma

ascendis-pharma-and-catalystone-1

About Ascendis Pharma

Ascendis Pharma is applying its innovative prodrug technology to build a leading, fully integrated rare disease company focused on making a meaningful difference in patients’ lives. The company utilizes its TransCon technology with clinically validated parent drugs to create new therapies with potential for best-in-class efficacy, safety and/or convenience. Ascendis Pharma is headquartered in Copenhagen, DK with presence also in Palo Alto, USA and Heidelberg, Germany.

Hope Mears Østgaard

Skrevet av Hope Mears Østgaard, 19 June 2018